Volume 150, Issue 6, Pages (December 2016)

Slides:



Advertisements
Similar presentations
Volume 138, Issue 3, Pages (September 2010)
Advertisements

Kanazawa Hiroshi , MD, Hirata Kazuto , MD, Yoshikawa Junichi , MD 
Lobarspirometry* Diseases of the Chest
Han-Pin Kuo, M.D., Ph.D., Chieh-Teng Yu, M.D.  CHEST 
Volume 112, Issue 5, Pages (November 1997)
Colloquium on Therapy of Right Heart Failure
Volume 151, Issue 1, Pages (January 2017)
Massive Hemoptysis Caused by a Ruptured Subclavian Artery Aneurysm
Environmental Causes of Cancer of the Lung Other Than Tobacco Smoke
Epidemiology and Treatment of Lung Cancer in Seattle
Effects of Medroxyprogesterone Acetate in Obstructive Sleep Apnea
Wan-Jie Gu, MSc, Chun-Yin Wei, MSc, Rui-Xing Yin, MD, PhD  CHEST 
Hyperbaric Oxygenation in Cardiac and Pulmonary Disease
Woman With Abdominal Pain and Diarrhea
Rhona Stein, Ph.D., David M. Goldenberg, Sc.D., M.D.  CHEST 
Volume 151, Issue 4, Pages (April 2017)
Air Pollution and Chest Disease
Single-Breath Washout Tests to Assess Small Airway Disease in COPD
Volume 148, Issue 5, Pages (November 2015)
Plasma Orexin-A Levels and Body Composition in COPD
Volume 151, Issue 3, Pages (March 2017)
A 51-Year-Old Woman With an Increasing Chest Wall Mass Years After Resection of an Early Stage Lung Cancer  Ajay Dhakal, MBBS, Hongbin Chen, MD, PhD,
A Critical Review of the Quality of Cough Clinical Practice Guidelines
Volume 152, Issue 5, Pages (November 2017)
Jianqiao Cai, MD, Jian Zhou, MD, Fan Yang, MD, Jun Wang, MD  CHEST 
The Therapeutic Potential of Hyaluronan in COPD
The Secret Life of America's Poison Centers
Volume 153, Issue 4, Pages (April 2018)
Volume 139, Issue 4, Pages (April 2011)
Volume 153, Issue 5, Pages (May 2018)
Volume 153, Issue 5, Pages (May 2018)
Zaid J. Yaqoob, MD, Sadeer G. Al-Kindi, MD, Joe G. Zein, MD  CHEST 
Volume 153, Issue 1, Pages (January 2018)
Precision Medicine Urgency
A 15-Year-Old Boy with Mysterious Variability in Apnea-Hypopnea Index
Volume 74, Issue 6, Pages (December 2018)
Volume 150, Issue 6, Pages (December 2016)
Efficacy and Safety of Abelmoschus manihot for Primary Glomerular Disease: A Prospective, Multicenter Randomized Controlled Clinical Trial  Li Zhang,
Maximal Midexpiratory Flow as an Index of Acute Airway Changes
Chronic Obstructive Pulmonary Disease: An Evidence-Based Approach to Treatment With a Focus on Anticholinergic Bronchodilation  Nicholas J. Gross, MD,
Peter Hountras, MD, Hector Cajigas, MD  CHEST 
Airway Stenting for Patients With Benign Airway Disease and the Food and Drug Administration Advisory  Lund Mark E. , MD, FCCP, Force Seth , MD, FCCP 
Evaluation of Pulmonary Nodules
Surgical treatment of pulmonary artery sarcoma
A Critical Review of the Quality of Cough Clinical Practice Guidelines
Sundeep Salvi, MD, DNB, PhD, FCCP, Peter J. Barnes, DM, FCCP  CHEST 
Volume 155, Issue 1, Pages (January 2019)
Imaging for the Management of Community-Acquired Pneumonia
Point: Should We Abandon FEV1/FVC <0
Rebuttal From Dr Mazzone
A Patient With Chest Pain and Hyperacute T Waves
Unusual Coin Lesion in the Lung
Po-Kuei Hsu, MD, PhD, Yu-Chung Wu, MD  CHEST 
Volume 155, Issue 1, Pages (January 2019)
Extracellular Adenosine 5'-Triphosphate in Obstructive Airway Diseases
Confronting the Colossal Crisis of COPD in China
Predictive Value of Intratumoral Microvascular Density in Patients with Advanced Non- small Cell Lung Cancer Receiving Chemotherapy Plus Bevacizumab  Yuan-Yuan.
Bedside Calibration Of Pulmonary Artery Catheters
Volume 154, Issue 4, Pages (October 2018)
Volume 42, Issue 2, Pages (August 1962)
Calcification of the Coronary Artery
Volume 150, Issue 4, Pages (October 2016)
Volume 143, Issue 6, Pages (June 2013)
David Bédard Méthot, MD, Évelyne Leblanc, MD, Yves Lacasse, MD  CHEST 
Genetic Syndromes and Outcome After Surgical Repair of Pulmonary Atresia and Ventricular Septal Defect  Meng-Yu Chen, MD, Shuenn-Nan Chiu, MD, PhD, Jou-Kou.
Volume 133, Issue 4, Pages (April 2008)
Use of Endobronchial Ultrasound for Bedside Diagnosis of Acute Pulmonary Embolism in a Critically Ill Patient  Colleen L. Channick, MD, FCCP, Richard.
Lung Density in Extremely Large Healthy Lungs
Stented elephant trunk procedure with left subclavian artery transposition for acute type B dissection with distal arch involvement  Jun-Ming Zhu, MD,
Lung Volume Reduction Surgery in the United States From 2007 to 2013
Presentation transcript:

Volume 150, Issue 6, Pages 1281-1290 (December 2016) Measuring Airway Remodeling in Patients With Different COPD Staging Using Endobronchial Optical Coherence Tomography  Ming Ding, PhD, Yu Chen, PhD, Wei-Jie Guan, PhD, Chang-Hao Zhong, MD, Mei Jiang, MD, Wei-Zhan Luo, MD, Xiao-Bo Chen, MD, Chun-Li Tang, MD, Yan Tang, MD, Qi-Ming Jian, MD, Wei Wang, MD, Shi-Yue Li, MD, Nan-Shan Zhong, MD  CHEST  Volume 150, Issue 6, Pages 1281-1290 (December 2016) DOI: 10.1016/j.chest.2016.07.033 Copyright © 2016 American College of Chest Physicians Terms and Conditions

Figure 1 Cross-sectional images of endobronchial optical coherence tomography (EB-OCT) in the (A) fifth-, (B) seventh-, and (C) ninth-generation bronchi. Compared with never-smokers (A1, B1, C1), stage III-IV in patients with COPD is characterized by the most significant mucosal thickening and blurred submucosal layer (A3, B3, C3), followed by heavy smokers with normal FEV1 (SNL) (A2, B2, C2). CHEST 2016 150, 1281-1290DOI: (10.1016/j.chest.2016.07.033) Copyright © 2016 American College of Chest Physicians Terms and Conditions

Figure 2 Longitudinal EB-OCT images demonstrating the morphologic differences of a never-smoker, SNL, and a patient with stage III COPD. Tapering of the inner airway lumen is most significant in (C) COPD (stage III, followed by (A) never-smokers and (B) SNL. See Figure 1 legend for expansion of abbreviations. CHEST 2016 150, 1281-1290DOI: (10.1016/j.chest.2016.07.033) Copyright © 2016 American College of Chest Physicians Terms and Conditions

Figure 3 Trends in tapering of EB-OCT parameters of each generation of bronchi among never-smokers, SNL, and patients with COPD. (A) The Ai7 of stage II COPD is smaller than that of stage I COPD (P = .017) but greater than that of stage III-IV COPD (P = .003). (B) Similar trend of changes seen in A. The dashed line indicates an inner airway diameter of 2 mm. * Indicates that the among-group differences are statistically significant. (C) # Indicates no significant difference between SNL and patients with COPD and among various stages of COPD (all P > .05). SNL present with greater airway wall thickness than do never-smokers in the seventh-, eighth-, and ninth-generation bronchi (all P < .001). GOLD = Global Initiative for Lung Disease. See Figure 1 legend for expansion of other abbreviations. CHEST 2016 150, 1281-1290DOI: (10.1016/j.chest.2016.07.033) Copyright © 2016 American College of Chest Physicians Terms and Conditions

Figure 4 Correlation between FEV1% predicted and Ai3-6, Ai7-9 and Aw3-6, Aw7-9. (A and B) Ai3-6 and Ai7-9 are significantly correlated with FEV1% predicted (r = 0.731; P < .001 and r = 0.768; P < .001). (C and D) Correlation is significant between Aw3-6 and FEV1% predicted (r = –0.591; P < .001) but not in Aw7-9 (r = 0.069; P = .575). Dashed lines correspond to COPD staging (ie, FEV1% predicted = 30%, 50%, and 80%). Aw = airway wall area. See Figure 3 legend for expansion of other abbreviations. CHEST 2016 150, 1281-1290DOI: (10.1016/j.chest.2016.07.033) Copyright © 2016 American College of Chest Physicians Terms and Conditions